Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?
Leukemia. 2018 Sep 10;:
Prognostic Implications of Point-of-Care and Serial B-type Natriuretic Peptide Levels in Patients With Hypertrophic Cardiomyopathy.
Am J Cardiol. 2018 Jul 19;:
Effects of everolimus and HLA-G on cellular proliferation and neutrophil adhesion in an in vitro model of cardiac allograft vasculopathy.
Am J Transplant. 2018 Jul 09;:
Hum Immunol. 2018 May 30;:
Distinct Patterns of Hyperpnea During Cheyne-Stokes Respiration: Implication for Cardiac Function in Patients With Heart Failure.
J Clin Sleep Med. 2017 Nov 15;13(11):1235-1241
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.
Vasc Health Risk Manag. 2017;13:293-303
Clin Lymphoma Myeloma Leuk. 2017 Jul 15;:
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
J Cardiovasc Magn Reson. 2017 Aug 07;19(1):61
High-risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure.
J Thorac Cardiovasc Surg. 2017 Mar 21;: